2,931 press releases indexed under healthcare.
SHIJIAZHUANG, China, July 9, 2026 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced that its MFG8 drug substance manufacturing facility located in Hebei has successfully passed the Pre-License...
Rong Diao of Morris Plains, New Jersey, has been named a Professional of the Year for 2026 in food/biotech by Strathmore's Who's Who Worldwide for her outstanding contributions and achievements in food, biotech, manufacturing, and research and development. About Rong Diao Rong Diao is an owner of Omni BioFood and a respected leader in the food and biotechnology industries. Omni BioFood specializes in research and [PR.com]
LINKÖPING, Sweden, July 9, 2026 /PRNewswire/ -- International medical imaging IT and cybersecurity company Sectra (STO: SECT B) announces that Dayton Children's Hospital is now live with Sectra's ophthalmology solution, extending the hospital's enterprise imaging platform beyond radiology....
Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology company, today announces the publication by expert clinicians of new consensus-based guidance - developed by them for the use of single-use negative pressure wound therapy (sNPWT) in closed surgical incisions. The guidance is supported by practical clinical practice recommendations for Germany and has been published in the internationally recognised journal of surgery Die Chirurgie. The new German consensus was supported by Smith+Nephew, a pioneer in sNPWT and manufacturer of the PICO™7 sNPWT system.
Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology company, today announces the publication of new consensus-based guidance - developed independently by expert clinicians for the use of single-use negative pressure wound therapy (sNPWT) in closed surgical incisions. The guidance is supported by practical clinical practice recommendations for Germany. Published in internationally recognised journal of surgery Die Chirurgie, the new German consensus was supported by Smith+Nephew, a pioneer in sNPWT and manufacturer of the PICO ™ 7 sNPWT system.
Basel, 9 July 2026 - Roche (SIX: RO, ROP; OTCQX: RHHBY) announced today that its Elecsys IGRA TB test has received the CE Mark, introducing a new blood testing solution for identifying tuberculosis infection (TBI, also known as latent TB) in routine laboratory settings. The new solution enables fast, simple, and efficient diagnosis, and can provide results in under 24 hours. The Interferon Gamma Release Assay (IGRA) itself takes just 19 minutes per patient to process, which is approximately half the time of currently used methods. Laboratories now have an option for IGRA testing, with faster turnaround and scalable throughput on Roche’s systems.
(PR-inside.com) "Government's Own Scientific Expert Testified Marijuana Failed DEA's Traditional Medical Use Standard, Lacked Reproducible Chemistry, and That HHS Omitted Critical Public Health Findings" stated Duane Boise CEO MMJ International Holdings. WASHINGTON, DC / ACCESS Newswire / July 8, 2026 / One witness may ultimately define the entire DEA marijuana rescheduling proceeding-not because she opposed marijuana legalization, but because she authored the Drug Enforcement Administration's own scientific review. Dr. Luli Akinfiresoye, a pharmacologist in DEA's Drug and Chemical Evaluation Section and author of the agency's 2024 Scientific Data Review, testified under subpoena during the marijuana rescheduling hearing. Her testimony revealed a striking scientific ..
Taiwan-listed biotech looks to expand the value of its lead oncology asset through combination research with late-stage cancer drug resistance specialist InxMed. TAIPEI and SHANGHAI and SAN FRANCISCO, July 8, 2026 /PRNewswire/ -- HanchorBio, Inc. (TWSE: 7827) is taking another step to...
CAMBRIDGE, Mass., July 8, 2026 /PRNewswire/ -- Insilico Medicine ("Insilico" or the "Company", HKEX: 3696), a generative artificial intelligence (AI)-driven clinical-stage biotech company, today delivered a positive profit alert for the six months ended June 30, 2026 ("First Half of...
HANGZHOU, China, SHANGHAI and BOSTON, July 8, 2026 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. ("Lynk Pharmaceuticals"), a clinical-stage innovative drug development company focused on immune and inflammatory diseases, today announced that the first patient was successfully dosed on...
In her moving and faith-filled memoir, “The Miracle of Eve: Saved by Grace!,” author Yvonne D. Baku opens her heart to readers with a story that is as vulnerable as it is victorious. What began as a season of unexplained pain, exhaustion, uncertainty, and medical appointments soon became a life-altering journey through a diagnosis of stage IV large B-cell non-Hodgkin's lymphoma — a journey that tested her body, her marriage, her family, her faith, and her understanding of purpose. - - At... Read the full story at https://www.webwire.com/ViewPressRel.asp?aId=357370
Cold laser therapy device manufacturer announces its dual-head LumaCare Duo device is now eligible for purchase using HSA and FSA funds through a new partnership with Flex. The post LumaCare Lasers Partners with Flex to Unlock HSA and FSA Funds for Cold Laser Therapy first appeared on